CXM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Sprinklr Inc (CXM) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The technical indicators, options data, and financial performance suggest a cautious approach, as the stock lacks clear upward momentum and faces challenges in growth and profitability. Holding off on purchasing this stock until stronger positive catalysts emerge or financial performance improves would be prudent.
The technical indicators for CXM are bearish. The MACD is below 0 and negatively contracting, suggesting weak momentum. The RSI is neutral at 50.181, providing no clear signal. Moving averages are bearish, with SMA_200 > SMA_20 > SMA_5. Key support and resistance levels indicate a pivot at 5.671, with resistance at 6.03 and support at 5.312. The stock has a 40% chance of declining in the short term based on candlestick pattern analysis.
No significant positive catalysts identified. The stock has no recent news, and hedge fund and insider trading trends are neutral. Analysts acknowledge the company's long-term strategic initiatives but highlight that growth reacceleration is unlikely before FY28.
Analysts have lowered price targets significantly, citing underwhelming guidance and delayed growth reacceleration. Financial performance in Q4 2026 showed a sharp decline in net income (-90.93% YoY) and EPS (-88.89% YoY), along with a drop in gross margin. Technical indicators are bearish, and the stock lacks upward momentum.
In Q4 2026, revenue increased by 8.91% YoY to $220.59 million. However, net income dropped by 90.93% YoY to $8.95 million, and EPS fell by 88.89% YoY to 0.04. Gross margin declined to 65.65%, down 7.48% YoY, indicating challenges in profitability.
Analysts have recently lowered price targets: Morgan Stanley to $7 from $10, DA Davidson to $6.50 from $9, Citizens to $11 from $17, and Citi to $7 from $9. Ratings are mixed, with Neutral and Outperform ratings, but concerns about delayed growth reacceleration and underwhelming guidance dominate.
